Skip to main content
OpenTrials

Clinical trial condition

Stage IIIA Breast Cancer AJCC v7

Explore clinical trials studying Stage IIIA Breast Cancer AJCC v7. Study availability and eligibility vary by location and protocol.

29 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IIIA Breast Cancer AJCC v7 trial results

Completed

Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

NCT00861705

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • NEA Baptist Memorial Hospital Jonesboro, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 448 locations
View Trial Details
Completed

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

NCT04054557

Conditions
Breast Carcinoma In Situ, Breast Diseases, Breast Neoplasms, +19 more
Locations
  • Jefferson Health - South Jersey Washington Township, New Jersey, United States
  • Thomas Jefefrson University Philadelphia, Pennsylvania, United States
  • Methodist Hospital Philadelphia, Pennsylvania, United States
  • Jefferson Health - Northeast Torresdale, Pennsylvania, United States
View Trial Details
Completed

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

NCT00770809

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • Sparks Regional Medical Center Fort Smith, Arkansas, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • East Bay Radiation Oncology Center Castro Valley, California, United States
View all 318 locations
View Trial Details
Completed

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

NCT02003209

Conditions
Breast Diseases, Breast Neoplasms, HER2-Positive Breast Carcinoma, +11 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
View all 732 locations
View Trial Details
Completed

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

NCT01275677

Conditions
Breast Diseases, Breast Neoplasms, HER2/Neu Positive, +12 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 1283 locations
View Trial Details
Completed

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

NCT01638533

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details

Related conditions